Novavax sh_老虎社区_美港股上老虎

2021-12-28

Novavax share price dropped further today as investors are anxious about the wait for FDA approval. Good time to bargain hunt if you like the stock. 🤔

Novavax shares dropped another 4% in premarket trading

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

RudolfKennedy
2021-12-28
RudolfKennedy
Hurry up and sell the vaccine stocks. 2022 You should buy stocks of companies whose businesses such as tourism and airlines are seriously affected by the epidemic.
- koolgal:
  That is a great idea.
waipoin
2021-12-28
waipoin
With or without FDA approval， Novavax's share price will plummet.
- 雁门关向东二万五千里:
  为什么会一直暴跌呢？给个理由？
- koolgal:
  Hope not.
dimsum
2021-12-28
dimsum
Retail investors should no longer consider buying vaccine stocks. The epidemic will end in 2022, and the share price of the epidemic beneficiary stocks will fall.
- koolgal回复bernardtayet:
  Thanks
- koolgal:
  For now with Omicron spreading like fire, vaccine companies are very much needed to produce more vaccines.
ladyman
2021-12-28
ladyman
No one knows how the epidemic will develop. However, Novavax's share price has risen for two years, and it is inevitable to start adjusting now.
- koolgal回复skyel:
  Thanks
- koolgal:
  Yes that is true.
falleno
2021-12-28
falleno
The global economy needs recovery. Vaccination benefits everyone in the world. There is nothing wrong with holding vaccine stocks at present.
- koolgal:
  Yes vaccine companies like Pfizer have been doing very well lately. Go Pfizer! 🚀🚀🚀🌙🌙🌙

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":696628586,"tweetId":"696628586","gmtCreate":1640686851880,"gmtModify":1640728380264,"author":{"id":3559581955535845,"authorId":3559581955535845,"authorIdStr":"3559581955535845","name":"koolgal","avatar":"https://static.tigerbbs.com/c05274d88ffc0434623e57350c52c70a","vip":2,"userType":2,"introduction":"Be Extraordinary Is My Motto In Life Because The Best Is Yet To Be!","boolIsFan":false,"boolIsHead":false,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[],"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Novavax share price dropped further today as investors are anxious about the wait for FDA approval.&nbsp; Good time to bargain hunt if you like the stock. 🤔</p></body></html>","htmlText":"<html><head></head><body><p>Novavax share price dropped further today as investors are anxious about the wait for FDA approval.&nbsp; Good time to bargain hunt if you like the stock. 🤔</p></body></html>","text":"Novavax share price dropped further today as investors are anxious about the wait for FDA approval. Good time to bargain hunt if you like the stock. 🤔","highlighted":2,"essential":1,"paper":1,"likeSize":27,"commentSize":21,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/696628586","repostId":1138246031,"repostType":4,"repost":{"id":"1138246031","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640683578,"share":"https://www.laohu8.com/m/news/1138246031?lang=&edition=full","pubTime":"2021-12-28 17:26","market":"us","language":"en","title":"Novavax shares dropped another 4% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1138246031","media":"Tiger Newspress","summary":"Novavax shares dropped another 4% in premarket trading.The stock plunged nearly 11% yesterday.\n\nWhy ","content":"<p>Novavax shares dropped another 4% in premarket trading.The stock plunged&nbsp;nearly 11% yesterday.</p>\n<p><img src=\"https://static.tigerbbs.com/04a11fff9a31214bbcf7595183a5d305\" tg-width=\"843\" tg-height=\"618\" referrerpolicy=\"no-referrer\"></p>\n<p><b>Why Novavax Stock Is Sinking</b></p>\n<p>The company didn't announce any new developments. So what's behind the big decline?</p>\n<p>Other&nbsp;vaccine stocks&nbsp;aren't falling nearly as much. Some were even up a little. That rules out the likelihood that declining concerns about the omicron variant played a major factor behind Novavax's drop.</p>\n<p>Instead, investors are probably growing more anxious about Novavax's planned filing for U.S. Emergency Use Authorization (EUA) of it COVID-19 vaccine NVX-CoV2373. Some investors could also be worried about the quality of Novavax's submission to the Food and Drug Administration (FDA) even if it doesn't experience another delay with the filing.</p>\n<p>CEO Stanley Erck's interview with Yahoo! Finance Live last Thursday likely didn't help reassure investors. When asked about when the FDA filing would be done, Erck replied, \"It's probably going to be next week, but I'm sticking with the claim that we'll be doing this by the end of this year.\"</p>\n<p><b>So what</b></p>\n<p>Yet another delay in a U.S. filing for NVX-CoV2373 wouldn't be catastrophic for Novavax as long as the company completes the submission soon in the new year. However, management's credibility would definitely take another big blow.</p>\n<p>But it's premature at this point to speculate that Novavax won't complete the U.S. EUA filing this week. It's also useless to fret about the quality of the company's FDA package. Novavax recently won European Union authorization for NVX-CoV2373. That shows that the vaccine maker can successfully meet regulators' manufacturing-quality hurdles.</p>\n<p><b>Now what</b></p>\n<p>Investors don't like waiting, but that's exactly what they'll have to do for now with Novavax. The company could complete its EUA filing any day now. It could also pick up new authorizations in other countries where it awaits regulatory decisions.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax shares dropped another 4% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax shares dropped another 4% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-28 17:26</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Novavax shares dropped another 4% in premarket trading.The stock plunged&nbsp;nearly 11% yesterday.</p>\n<p><img src=\"https://static.tigerbbs.com/04a11fff9a31214bbcf7595183a5d305\" tg-width=\"843\" tg-height=\"618\" referrerpolicy=\"no-referrer\"></p>\n<p><b>Why Novavax Stock Is Sinking</b></p>\n<p>The company didn't announce any new developments. So what's behind the big decline?</p>\n<p>Other&nbsp;vaccine stocks&nbsp;aren't falling nearly as much. Some were even up a little. That rules out the likelihood that declining concerns about the omicron variant played a major factor behind Novavax's drop.</p>\n<p>Instead, investors are probably growing more anxious about Novavax's planned filing for U.S. Emergency Use Authorization (EUA) of it COVID-19 vaccine NVX-CoV2373. Some investors could also be worried about the quality of Novavax's submission to the Food and Drug Administration (FDA) even if it doesn't experience another delay with the filing.</p>\n<p>CEO Stanley Erck's interview with Yahoo! Finance Live last Thursday likely didn't help reassure investors. When asked about when the FDA filing would be done, Erck replied, \"It's probably going to be next week, but I'm sticking with the claim that we'll be doing this by the end of this year.\"</p>\n<p><b>So what</b></p>\n<p>Yet another delay in a U.S. filing for NVX-CoV2373 wouldn't be catastrophic for Novavax as long as the company completes the submission soon in the new year. However, management's credibility would definitely take another big blow.</p>\n<p>But it's premature at this point to speculate that Novavax won't complete the U.S. EUA filing this week. It's also useless to fret about the quality of the company's FDA package. Novavax recently won European Union authorization for NVX-CoV2373. That shows that the vaccine maker can successfully meet regulators' manufacturing-quality hurdles.</p>\n<p><b>Now what</b></p>\n<p>Investors don't like waiting, but that's exactly what they'll have to do for now with Novavax. The company could complete its EUA filing any day now. It could also pick up new authorizations in other countries where it awaits regulatory decisions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1138246031","content_text":"Novavax shares dropped another 4% in premarket trading.The stock plunged nearly 11% yesterday.\n\nWhy Novavax Stock Is Sinking\nThe company didn't announce any new developments. So what's behind the big decline?\nOther vaccine stocks aren't falling nearly as much. Some were even up a little. That rules out the likelihood that declining concerns about the omicron variant played a major factor behind Novavax's drop.\nInstead, investors are probably growing more anxious about Novavax's planned filing for U.S. Emergency Use Authorization (EUA) of it COVID-19 vaccine NVX-CoV2373. Some investors could also be worried about the quality of Novavax's submission to the Food and Drug Administration (FDA) even if it doesn't experience another delay with the filing.\nCEO Stanley Erck's interview with Yahoo! Finance Live last Thursday likely didn't help reassure investors. When asked about when the FDA filing would be done, Erck replied, \"It's probably going to be next week, but I'm sticking with the claim that we'll be doing this by the end of this year.\"\nSo what\nYet another delay in a U.S. filing for NVX-CoV2373 wouldn't be catastrophic for Novavax as long as the company completes the submission soon in the new year. However, management's credibility would definitely take another big blow.\nBut it's premature at this point to speculate that Novavax won't complete the U.S. EUA filing this week. It's also useless to fret about the quality of the company's FDA package. Novavax recently won European Union authorization for NVX-CoV2373. That shows that the vaccine maker can successfully meet regulators' manufacturing-quality hurdles.\nNow what\nInvestors don't like waiting, but that's exactly what they'll have to do for now with Novavax. The company could complete its EUA filing any day now. It could also pick up new authorizations in other countries where it awaits regulatory decisions.","news_type":1},"isVote":1,"tweetType":1,"viewCount":2083,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["NVAX"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":125,"xxTargetLangEnum":"ZH_CN"},"commentList":[{"id":7127576,"gmtCreate":1640692642732,"gmtModify":1640692642732,"authorId":9000000000000404,"author":{"id":9000000000000404,"authorId":9000000000000404,"name":"RudolfKennedy","avatar":"https://static.tigerbbs.com/4bf2f8692df593c0e58239fd56abf27c","vip":8,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":696628586,"type":1,"supId":0,"prevId":0,"content":"Hurry up and sell the vaccine stocks. 2022 You should buy stocks of companies whose businesses such as tourism and airlines are seriously affected by the epidemic.","text":"Hurry up and sell the vaccine stocks. 2022 You should buy stocks of companies whose businesses such as tourism and airlines are seriously affected by the epidemic.","html":"Hurry up and sell the vaccine stocks. 2022 You should buy stocks of companies whose businesses such as tourism and airlines are seriously affected by the epidemic.","likeSize":4,"commentSize":1,"subComments":[{"id":7130023,"gmtCreate":1640728403761,"gmtModify":1640728403761,"authorId":3559581955535845,"author":{"id":3559581955535845,"authorId":3559581955535845,"name":"koolgal","avatar":"https://static.tigerbbs.com/c05274d88ffc0434623e57350c52c70a","vip":2,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":696628586,"type":1,"supId":7127576,"prevId":0,"content":"That is a great idea.","text":"That is a great idea.","html":"That is a great idea."}],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0},{"id":7127565,"gmtCreate":1640692502658,"gmtModify":1640692502658,"authorId":3479274815585833,"author":{"id":3479274815585833,"authorId":3479274815585833,"name":"waipoin","avatar":"https://static.laohu8.com/picture184","vip":8,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":696628586,"type":1,"supId":0,"prevId":0,"content":"With or without FDA approval， Novavax's share price will plummet.","text":"With or without FDA approval， Novavax's share price will plummet.","html":"With or without FDA approval， Novavax's share price will plummet.","likeSize":2,"commentSize":2,"subComments":[{"id":7140979,"gmtCreate":1640868917545,"gmtModify":1640868917545,"authorId":4092177932484180,"author":{"id":4092177932484180,"authorId":4092177932484180,"name":"雁门关向东二万五千里","avatar":"https://static.tigerbbs.com/f8028d384edafa7b6d189626466fbab1","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":696628586,"type":1,"supId":7127565,"prevId":0,"content":"为什么会一直暴跌呢？给个理由？","text":"为什么会一直暴跌呢？给个理由？","html":"为什么会一直暴跌呢？给个理由？"},{"id":7130043,"gmtCreate":1640728497233,"gmtModify":1640728497233,"authorId":3559581955535845,"author":{"id":3559581955535845,"authorId":3559581955535845,"name":"koolgal","avatar":"https://static.tigerbbs.com/c05274d88ffc0434623e57350c52c70a","vip":2,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":696628586,"type":1,"supId":7127565,"prevId":0,"content":"Hope not.&nbsp;","text":"Hope not.&nbsp;","html":"Hope not.&nbsp;"}],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0},{"id":7127559,"gmtCreate":1640692398844,"gmtModify":1640692398844,"authorId":3479274804998780,"author":{"id":3479274804998780,"authorId":3479274804998780,"name":"dimsum","avatar":"https://static.laohu8.com/picture163","vip":8,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":696628586,"type":1,"supId":0,"prevId":0,"content":"Retail investors should no longer consider buying vaccine stocks. The epidemic will end in 2022, and the share price of the epidemic beneficiary stocks will fall.","text":"Retail investors should no longer consider buying vaccine stocks. The epidemic will end in 2022, and the share price of the epidemic beneficiary stocks will fall.","html":"Retail investors should no longer consider buying vaccine stocks. The epidemic will end in 2022, and the share price of the epidemic beneficiary stocks will fall.","likeSize":2,"commentSize":2,"subComments":[{"id":7131218,"gmtCreate":1640736731843,"gmtModify":1640736731843,"authorId":3559581955535845,"author":{"id":3559581955535845,"authorId":3559581955535845,"name":"koolgal","avatar":"https://static.tigerbbs.com/c05274d88ffc0434623e57350c52c70a","vip":2,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":3583377018896117,"repliedAuthor":{"id":3583377018896117,"authorId":3583377018896117,"name":"bernardtayet","avatar":"https://static.tigerbbs.com/43e8c1fc37a4bff2a94af98953cff267","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"objectId":696628586,"type":1,"supId":7127559,"prevId":7130684,"content":"Thanks","text":"Thanks","html":"Thanks"},{"id":7130048,"gmtCreate":1640728555795,"gmtModify":1640728555795,"authorId":3559581955535845,"author":{"id":3559581955535845,"authorId":3559581955535845,"name":"koolgal","avatar":"https://static.tigerbbs.com/c05274d88ffc0434623e57350c52c70a","vip":2,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":696628586,"type":1,"supId":7127559,"prevId":0,"content":"For now with Omicron spreading like fire, vaccine companies are very much needed to produce more vaccines.","text":"For now with Omicron spreading like fire, vaccine companies are very much needed to produce more vaccines.","html":"For now with Omicron spreading like fire, vaccine companies are very much needed to produce more vaccines."}],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0},{"id":7127584,"gmtCreate":1640692715106,"gmtModify":1640692715106,"authorId":3479274804085724,"author":{"id":3479274804085724,"authorId":3479274804085724,"name":"ladyman","avatar":"https://static.laohu8.com/picture161","vip":8,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":696628586,"type":1,"supId":0,"prevId":0,"content":"No one knows how the epidemic will develop. However, Novavax's share price has risen for two years, and it is inevitable to start adjusting now.","text":"No one knows how the epidemic will develop. However, Novavax's share price has risen for two years, and it is inevitable to start adjusting now.","html":"No one knows how the epidemic will develop. However, Novavax's share price has risen for two years, and it is inevitable to start adjusting now.","likeSize":2,"commentSize":2,"subComments":[{"id":7130019,"gmtCreate":1640728380220,"gmtModify":1640728380220,"authorId":3559581955535845,"author":{"id":3559581955535845,"authorId":3559581955535845,"name":"koolgal","avatar":"https://static.tigerbbs.com/c05274d88ffc0434623e57350c52c70a","vip":2,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":3581505866102985,"repliedAuthor":{"id":3581505866102985,"authorId":3581505866102985,"name":"skyel","avatar":"https://static.tigerbbs.com/a4e416c9b1fabad56fbe0e086388d5b0","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"objectId":696628586,"type":1,"supId":7127584,"prevId":7128216,"content":"Thanks","text":"Thanks","html":"Thanks"},{"id":7130018,"gmtCreate":1640728374741,"gmtModify":1640728374741,"authorId":3559581955535845,"author":{"id":3559581955535845,"authorId":3559581955535845,"name":"koolgal","avatar":"https://static.tigerbbs.com/c05274d88ffc0434623e57350c52c70a","vip":2,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":696628586,"type":1,"supId":7127584,"prevId":0,"content":"Yes that is true.","text":"Yes that is true.","html":"Yes that is true."}],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0},{"id":7127571,"gmtCreate":1640692557152,"gmtModify":1640692557152,"authorId":3479274794883866,"author":{"id":3479274794883866,"authorId":3479274794883866,"name":"falleno","avatar":"https://static.laohu8.com/picture143","vip":8,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":696628586,"type":1,"supId":0,"prevId":0,"content":"The global economy needs recovery. Vaccination benefits everyone in the world. There is nothing wrong with holding vaccine stocks at present.","text":"The global economy needs recovery. Vaccination benefits everyone in the world. There is nothing wrong with holding vaccine stocks at present.","html":"The global economy needs recovery. Vaccination benefits everyone in the world. There is nothing wrong with holding vaccine stocks at present.","likeSize":3,"commentSize":1,"subComments":[{"id":7130035,"gmtCreate":1640728461721,"gmtModify":1640728461721,"authorId":3559581955535845,"author":{"id":3559581955535845,"authorId":3559581955535845,"name":"koolgal","avatar":"https://static.tigerbbs.com/c05274d88ffc0434623e57350c52c70a","vip":2,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":696628586,"type":1,"supId":7127571,"prevId":0,"content":"Yes vaccine companies like Pfizer have been doing very well lately. Go Pfizer! 🚀🚀🚀🌙🌙🌙","text":"Yes vaccine companies like Pfizer have been doing very well lately. Go Pfizer! 🚀🚀🚀🌙🌙🌙","html":"Yes vaccine companies like Pfizer have been doing very well lately. Go Pfizer! 🚀🚀🚀🌙🌙🌙"}],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0}],"isCommentEnd":false,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/696628586"}